COYA News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

CO

Mkt Cap

$99.7M

Volume

125.61K

Next Earnings

November 11th

Chart Financials Earnings News About Insider Filings

$32 Million Exosome Therapy Market Assessment 2026: Set to Experience Massive Growth, Reaching $1.4 Billion by 2040The global exosome therapy market is projected to grow from $32 million in 2026 to $1.4 billion by 2040, with a CAGR of 41.1%. Key growth drivers include expanding clinical pipelines, increased regulatory filings, and rising investment in regenerative medicine. Ophthalmology and oncology represent major therapeutic areas, while Asia-Pacific is positioned as a leading market. However, challenges include inconsistent therapeutic preparations, contamination risks, and quality control complexities.GlobeNewswire Inc. · Sep 7, 2026

Dr. Reddy's (RDY), COYA Ink Deal to Develop COYA 302 for ALSDr. Reddy's (RDY) enters into a licensing agreement with Coya Therapeutics to develop and commercialize the latter's ALS investigational combination therapy, COYA 302.Zacks Investment Research · Dec 7, 2023

Rare Stock Picks In August 2023 - From 34 Discerning AnalystsWe've compiled a list of August investment picks that you may have missed. Some Seeking Alpha analysts are more discerning by nature. See their Buy recommendations here.Seeking Alpha · Sep 3, 2023

Analyst Expectations for Coya Therapeutics's FutureWithin the last quarter, Coya Therapeutics (NASDAQ:COYA) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 8 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 3 0 0 0 0 3M Ago 4 0 0 0 0 According to 8 analyst offering 12-month price targets in the last 3 months, Coya Therapeutics has an average price target of $19.75 with a high of $28.00 and a low of $9.00. Below is a summary of how these ...Full story available on Benzinga.comBenzinga · Jul 17, 2023

The Latest Analyst Ratings for Coya TherapeuticsCoya Therapeutics (NASDAQ:COYA) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 9 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 5 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 2 0 0 0 0 These 9 analysts have an average price target of $18.33 versus the current price of Coya Therapeutics at $4.715, implying upside. Below is a summary of how these 9 analysts rated Coya Therapeutics over ...Full story available on Benzinga.comBenzinga · Jun 8, 2023

Marsh & McLennan To Rally Around 14%? Here Are 10 Other Analyst Forecasts For ThursdayRaymond James cut the price target for Brinker International, Inc. (NYSE: EAT) from $46 to $42.5. Raymond James analyst Brian Vaccaro maintained an Outperform rating. Brinker shares fell 6.3% to close at $36.39 on Tuesday. Telsey Advisory Group lowered the price target for Oxford Industries, Inc. (NYSE: OXM) from $125 to $115. Telsey Advisory Group analyst Dana Telsey maintained a Market Perform rating. Oxford Industries shares fell 5.8% to $101.00 in pre-market trading. Morgan Stanley cut the price target for Carrier Global Corporation (NYSE: CARR) from $49 to $47. Morgan Stanley analyst Betsy Graseck downgraded the stock from Overweight to Equal-Weight. Carrier Global shares fell 3.3% to $44.11 in pre-market trading. Jefferies slashed Wynn Resorts, Limited (NASDAQ: WYNN) price target from $135 ...Benzinga · Jun 8, 2023

Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving PremarketGainers Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 85.8% to $0.7985 in pre-market trading. Chijet Motor Company, Inc. (NASDAQ: TTOO) shares surged 51.3% to $0.1060 in pre-market trading after dipping around 31% on Monday. T2 Biosystems reported submission for the FDA breakthrough device designation for candida auris diagnostic test. Secoo Holding Limited (NASDAQ: SECO) gained 35.8% to $1.100 in pre-market trading. Zura Bio Limited (NASDAQ: ZURA) shares gained 35.4% to $8.79 in pre-market trading after the company completed approximately $80 million financing with the focus on advancing ZB-106, a potential first-in-class anti-IL-17 and anti-BAFF dual antagonist. Greenlane Holdings, Inc. (NASDAQ: GNLN) gained 29.5% to $0.36 in pre-market trading. Greenlane reported effectiveness of previously announced reverse stock split. GitLab Inc. (NASDAQ: GTLB) shares rose 27.6% to $45.18 in pre-market trading following better-than-expected first-quarter results. Regional Health Properties, Inc. (NYSE: RHE) shares climbed ...Benzinga · Jun 6, 2023

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023Upgrades According to CIBC, the prior rating for BlackBerry Ltd (NYSE:BB) was changed from Underperformer to Neutral. In the fourth quarter, BlackBerry showed an EPS of $0.02, compared to $0.01 from the year-ago quarter. The stock has a 52-week-high of $7.20 and a 52-week-low of $3.17. At the end of the last trading period, BlackBerry closed at $5.38. Evercore ISI Group upgraded the previous rating for Teva Pharmaceutical Industries Ltd (NYSE:TEVA) from In-Line to Outperform. In the first quarter, Teva Pharmaceutical Indus showed an EPS of $0.40, compared to $0.55 from the year-ago quarter. The current stock performance of Teva Pharmaceutical Indus shows a 52-week-high of $11.45 and a 52-week-low of $6.78. Moreover, at the end of the last trading period, the closing price was at $8.13. According to B of A Securities, the prior rating for Cincinnati Financial Corp (NASDAQ:CINF) was changed from Neutral to Buy. Cincinnati Financial earned $0.89 in the first quarter, compared to $1.58 in the year-ago quarter. The current stock performance of Cincinnati Financial shows a 52-week-high of $130.66 and a 52-week-low of $88.67. Moreover, at the end of the last trading period, the closing price was at $102.69. According to UBS, the prior rating for Albemarle Corp (NYSE:ALB) was changed from Neutral to Buy. For the first quarter, Albemarle had an EPS of $10.32, compared to year-ago quarter EPS of $2.38. At the moment, the stock has a 52-week-high of $334.20 and a 52-week-low of $171.82. Albemarle closed at $207.99 at the end of the last trading period. BTIG upgraded the previous rating for Dynatrace Inc (NYSE:DT) from Neutral to Buy. Dynatrace earned $0.31 in the fourth quarter, compared to $0.17 in the year-ago quarter. The stock has a 52-week-high of $48.00 and a 52-week-low of $31.55. At the end of the last trading period, Dynatrace closed at $47.07. According to Mizuho, the prior rating for WEC Energy Group Inc (NYSE:WEC) was changed from Neutral to Buy. WEC Energy Group earned $1.61 in the first quarter, compared to $1.79 in the year-ago quarter. At the moment, the stock has a 52-week-high of $108.39 and a 52-week-low of $80.91. WEC Energy Group closed at $89.27 at the end of the last trading period. For Rambus Inc (NASDAQ:RMBS), Jefferies upgraded the previous rating of Hold to Buy. Rambus earned $0.03 in the first quarter, compared to $0.01 in the year-ago quarter. At the moment, the stock has a 52-week-high of $54.23 and a 52-week-low of $20.00. Rambus closed at $53.55 at the end of the last trading period. According to Citigroup, the prior rating for Tencent Music Entertainment Group (NYSE:TME) was changed from Neutral to Buy. Tencent Music Enter Gr earned $0.13 in the first quarter, compared to $0.09 in the year-ago quarter. The stock has a 52-week-high of $9.29 and a 52-week-low of $3.15. At the end of the last trading period, Tencent Music Enter Gr closed at $8.31. Roth Capital upgraded the previous rating for Snap-on Inc (NYSE:SNA) from Neutral to Buy. Snap-on earned $4.60 in the first quarter, compared to $4.00 in the year-ago quarter. The stock has a 52-week-high of $265.02 and a 52-week-low of $190.37. At the end of the last trading period, Snap-on closed at $257.53. According to National Bank Financial Inc, the prior rating for Ritchie Bros Auctioneers Inc (NYSE:RBA) was changed from Sector Perform to Outperform. In the first quarter, Ritchie Bros Auctioneers showed an EPS of $0.57, compared to $0.46 from the year-ago quarter. At the moment, the stock has a 52-week-high of $72.68 and a 52-week-low of $48.75. Ritchie Bros Auctioneers closed at $51.85 at the end of the last trading period. See all analyst ratings upgrades. Downgrades For XP Inc (NASDAQ:XP), Banco Bradesco BBI S.A downgraded the previous rating of Outperform to Neutral. XP earned $0.28 in the first quarter, compared to $0.28 in the year-ago quarter. At the moment, the stock has a 52-week-high of $25.18 and a 52-week-low of $10.30. ...Full story available on Benzinga.comBenzinga · May 18, 2023

Here's Why Momentum in Coya Therapeutics, Inc. (COYA) Should Keep goingIf you are looking for stocks that are well positioned to maintain their recent uptrend, Coya Therapeutics, Inc. (COYA) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.Zacks Investment Research · May 16, 2023

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023Upgrades For The Trade Desk Inc (NASDAQ:TTD), Vertical Research upgraded the previous rating of Neutral to Positive. Trade Desk earned $0.38 in the fourth quarter, compared to $0.42 in the year-ago quarter. The current stock performance of Trade Desk shows a 52-week-high of $76.74 and a 52-week-low of $39.01. Moreover, at the end of the last trading period, the closing price was at $62.58. For LeMaitre Vascular Inc (NASDAQ:LMAT), Barrington Research upgraded the previous rating of Market Perform to Outperform. LeMaitre Vascular earned $0.27 in the first quarter, compared to $0.27 in the year-ago quarter. The current stock performance of LeMaitre Vascular shows a 52-week-high of $56.38 and a 52-week-low of $38.32. Moreover, at the end of the last trading period, the closing price was at $54.75. For Zimmer Biomet Holdings Inc (NYSE:ZBH), B of A Securities upgraded the previous rating of Underperform to Neutral. For the first quarter, Zimmer Biomet Holdings had an EPS of $1.89, compared to year-ago quarter EPS of $1.61. The current stock performance of Zimmer Biomet Holdings shows a 52-week-high of $149.25 and a 52-week-low of $100.41. Moreover, at the end of the last trading period, the closing price was at $143.01. Bernstein upgraded the previous rating for Marriott International Inc (NASDAQ:MAR) from Market Perform to Outperform. For the first quarter, Marriott Intl had an EPS of $2.09, compared to year-ago quarter EPS of $1.25. The stock has a 52-week-high of $183.33 and a 52-week-low of $131.02. At the end of the last trading period, Marriott Intl closed at $178.61. B of A Securities upgraded the previous rating for CNA Financial Corp (NYSE:CNA) from Underperform to Neutral. For the first quarter, CNA Financial had an EPS of $1.19, compared to year-ago quarter EPS of $1.16. At the moment, the stock has a 52-week-high of $47.51 and a 52-week-low of $35.92. CNA Financial closed at $39.28 at the end of the last trading period. B of A Securities upgraded the previous rating for Cogent Communications Holdings Inc (NASDAQ:CCOI) from Underperform to Buy. Cogent Comms Hldgs earned $0.02 in the fourth quarter, compared to $0.39 in the year-ago quarter. At the moment, the stock has a 52-week-high of $71.32 and a 52-week-low of $46.88. Cogent Comms Hldgs closed at $68.13 at the end of the last trading period. Craig-Hallum upgraded the previous rating for Advanced Micro Devices Inc (NASDAQ:AMD) from Hold to Buy. Advanced Micro Devices earned $0.60 in the first quarter, compared to $1.13 in the year-ago quarter. The current stock performance of Advanced Micro Devices shows a 52-week-high of $109.57 and a 52-week-low of $54.58. Moreover, at the end of the last trading period, the closing price was at $89.91. According to Susquehanna, the prior rating for Uber Technologies Inc (NYSE:UBER) was changed from Neutral to Positive. Uber Technologies earned $0.08 in the first quarter, compared to $0.18 in the year-ago quarter. The current stock performance of Uber Technologies shows a 52-week-high of $37.58 and a 52-week-low of $19.90. Moreover, at the end of the last trading period, the closing price was at $36.52. For Chewy Inc (NYSE:CHWY), Raymond James upgraded the previous rating of Market Perform to Outperform. Chewy earned $0.01 in the fourth quarter, compared to $0.16 in the year-ago quarter. The current stock performance of Chewy shows a 52-week-high of $52.88 and a 52-week-low of $22.23. Moreover, at the end of the last trading period, the closing price was at $31.10. Wolfe Research upgraded the previous rating for Prosperity Bancshares Inc (NYSE:PB) from Underperform to Outperform. In the first quarter, Prosperity Bancshares showed an EPS of $1.37, compared to $1.33 from the year-ago quarter. The stock has a 52-week-high of $78.76 and a 52-week-low of $58.21. At the end of the last trading period, Prosperity Bancshares closed at $59.14. For E2open Parent Holdings Inc (NYSE:ETWO), Credit Suisse upgraded the previous rating of Underperform to Neutral. For ...Full story available on Benzinga.comBenzinga · May 3, 2023

CO

COYACoya Therapeutics, Inc. Common Stock

COYA

Pay with—

Available Balance0.00

Your PositionYou don't own any COYA yet.

Related Tickers

Earnings